workhorse lesions

Related by string. * workhorses . Workhorses . Workhorse : ISRO workhorse PSLV . workhorse Miikka Kiprusoff . workhorse Nathan Hindmarsh . Workhorse Custom Chassis . nature microscopic workhorses . workhorse notebooks / Lesions . Lesion . lesioned : metastatic lesions . target lesion revascularization . pigmented lesions rejuvenate . benign lesions . precursor lesions * *

Related by context. Frequent words. (Click for all words.) 67 Taxus Stent 67 TAXUS ® 64 TAXUS Element Stent 64 XIENCE V demonstrated 64 patients undergoing percutaneous 63 stenoses 62 XIENCE V vs. 62 events MACE 62 paclitaxel eluting stents 62 undergoing coronary artery 62 TAXUS p value 61 paclitaxel eluting stent 61 TAXUS Express 60 drug eluting coronary stent 60 TAXUS Liberte 60 J Am Coll 60 TAXUS Stent 59 SPIRIT III 58 stroke myocardial infarction 58 Stent System 58 primary percutaneous coronary 58 mg QD 58 plus prednisone 57 Percutaneous Coronary Intervention 57 Median survival 57 Pivotal Trial 57 active comparator 57 TAXUS R 57 TAXUS stent 57 plus methotrexate 57 tolvaptan 57 plus gemcitabine 57 tirofiban 57 relapsed refractory multiple myeloma 57 CYPHER ® Stent 57 Patients Undergoing 56 stent implantation 56 TAXUS Liberte stent 56 Stenting 56 systemic embolism 56 carotid intima media 56 neoadjuvant 56 Thrombolysis 56 Am J Cardiol 56 retrospectively reviewed 56 NYHA Class II 56 coronary intervention 56 CYPHER R Stent 56 plus dexamethasone 55 phase IIb clinical 55 target lesion revascularization 55 fluvastatin 55 TAXUS 55 stent restenosis 55 endarterectomy 55 myocardial infarction stroke 55 coronary interventions 55 thrombotic events 55 cerebrovascular events 55 transurethral resection 54 radical nephrectomy 54 irbesartan 54 coronary stenting 54 Secondary endpoints include 54 label multicenter 54 coronary revascularization 54 carotid artery stenting 54 randomized multicenter 54 pericardial effusion 54 target vessel revascularization 54 paclitaxel eluting coronary stent 54 left ventricular systolic 53 acute coronary syndromes ACS 53 median PFS 53 carboplatin paclitaxel 53 stable angina 53 repeat revascularization 53 nonfatal myocardial infarction 53 Secondary endpoints included 53 lymphadenectomy 53 Carotid 53 prospectively defined 53 bendamustine 53 discontinuations due 53 seroprotection 53 estimated glomerular filtration 53 #:#-# [031] 53 CK MB 53 Response Evaluation Criteria 53 SPIRIT IV 52 revascularisation 52 carotid stenosis 52 placebo p = 52 lung metastases 52 unfractionated heparin 52 % CI #.#-#.# [003] 52 serum phosphorus 52 FOLFOX4 52 mg kg dose 52 cardiovascular hospitalization 52 Ischemic

Back to home page